Literature DB >> 1327607

Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests.

H A van Diemen1, P Lanting, J C Koetsier, R L Strijers, H K van Walbeek, C H Polman.   

Abstract

In 22 patients with clinically definite multiple sclerosis (MS) who were without visual symptoms and had a visual acuity of at least 1.0 in both eyes at the time of measurement, the following tests were performed to detect subclinical lesions in the visual system: visual evoked potential (VEP), contrast sensitivity test (CS), flight of colours test (FOC), colour vision test (Ishihara plates) (CV) and the pupillary light reflex (PLR). VEP was abnormal in 81.8%, CS in 72.7%, FOC in 36.4%, CV in 31.8%, and PLR in 52.3% of the patients. VEP and CS together were most sensitive: combining these techniques subclinical lesions of the visual system were detected in 90.9% (20/22) of these asymptomatic patients.

Entities:  

Mesh:

Year:  1992        PMID: 1327607     DOI: 10.1016/0303-8467(92)90088-k

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

Review 1.  Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.

Authors:  Elizabeth Silbermann; Lindsey Wooliscroft; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-19       Impact factor: 5.081

2.  Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial.

Authors:  Sarah A Morrow; J Alexander Fraser; Chad Day; Denise Bowman; Heather Rosehart; Marcelo Kremenchutzky; Michael Nicolle
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

3.  Frequency doubling illusion VEPs and automated perimetry in multiple sclerosis.

Authors:  Rasa Ruseckaite; Teddy Maddess; Gytis Danta; Andrew Charles James
Journal:  Doc Ophthalmol       Date:  2006-08-12       Impact factor: 2.379

4.  Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.

Authors:  Erin E Longbrake; Samantha Lancia; Nhial Tutlam; Kathryn Trinkaus; Robert T Naismith
Journal:  Mult Scler Relat Disord       Date:  2016-11-04       Impact factor: 4.339

5.  Contrast Sensitivity versus Visual Evoked Potentials in Multiple Sclerosis.

Authors:  Javad Heravian Shandiz; Abbas Nourian; Mercedeh Bahr Hossaini; Hadi Ostadi Moghaddam; Abbas-Ali Yekta; Laleh Sharifzadeh; Parviz Marouzi
Journal:  J Ophthalmic Vis Res       Date:  2010-07

6.  Functional Evaluation of the Visual Pathway in Patients with Multiple Sclerosis Using a Multifunction Stimulator Monitor.

Authors:  M Satue; L Jarauta; J Obis; M Cipres; M J Rodrigo; C Almarcegui; I Dolz; J R Ara; J Martin; L E Pablo; E Garcia-Martin
Journal:  J Ophthalmol       Date:  2019-09-18       Impact factor: 1.909

7.  Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.

Authors:  Fatih C Gundogan; Ahmet Tas; Salih Altun; Oguzhan Oz; Uzeyir Erdem; Gungor Sobaci
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

8.  Color blindness among multiple sclerosis patients in Isfahan.

Authors:  Vahid Shaygannejad; Khodayar Golabchi; Alireza Dehghani; Fereshteh Ashtari; Sepehr Haghighi; Mahsa Mirzendehdel; Majid Ghasemi
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.